Olmsted Syndrome: Comprehensive Clinical Overview for Healthcare Professionals with Current Evidence-Based Insights

Definition & EpidemiologyOlmsted syndrome (OS; OMIM #164900) is an extremely rare, non-neoplastic congenital disorder characterized by progressive, symmetrical, mutilating palmoplantar keratoderma (PPK) with periorificial hyperkeratotic lesions. First described in 1928…

Continue ReadingOlmsted Syndrome: Comprehensive Clinical Overview for Healthcare Professionals with Current Evidence-Based Insights

Comprehensive Clinical Review: Menkes Disease – Pathophysiology, Diagnosis, Management, and Emerging Therapeutics

1. Genetic Basis and Pathophysiology Menkes disease (MD; OMIM #309400) is an X-linked recessive disorder caused by pathogenic variants in the ATP7A gene (chromosome Xq21.1), which encodes a P-type ATPase…

Continue ReadingComprehensive Clinical Review: Menkes Disease – Pathophysiology, Diagnosis, Management, and Emerging Therapeutics

Comprehensive Clinical Overview of 48,XXYY Syndrome: Pathogenesis, Phenotype, Diagnosis, Management, and Prognosis

Epidemiology and Classification 48,XXYY syndrome is a rare sex chromosome aneuploidy affecting approximately 1 in 18,000–50,000 male births. It falls under the broader spectrum of Klinefelter variant syndromes, which includes…

Continue ReadingComprehensive Clinical Overview of 48,XXYY Syndrome: Pathogenesis, Phenotype, Diagnosis, Management, and Prognosis

Juvenile Idiopathic Arthritis (JIA): A Clinically Oriented Update Based on Current Evidence

Prepared for the Practicing Rheumatologist / Pediatrician Definition & Epidemiology Juvenile Idiopathic Arthritis (JIA) is a heterogeneous group of chronic arthritides of unknown etiology onset before age 16, persisting ≥6…

Continue ReadingJuvenile Idiopathic Arthritis (JIA): A Clinically Oriented Update Based on Current Evidence

Comprehensive Clinical Review of Peritoneal Mesothelioma: Epidemiology, Diagnosis, Pathogenesis, and Evidence-Based Management

Overview & Definition Peritoneal mesothelioma (PM) is a rare, aggressive malignancy arising from the mesothelial cells lining the peritoneum—the serous membrane encapsulating abdominal organs. accounting for 10–30% of all malignant…

Continue ReadingComprehensive Clinical Review of Peritoneal Mesothelioma: Epidemiology, Diagnosis, Pathogenesis, and Evidence-Based Management

Comprehensive Clinical Update on Silicosis: Pathophysiology, Diagnosis, Management, and Prevention—Incorporating 2024 Guidelines and Evidence

1. Background & Epidemiology Crystalline silica (SiO₂), predominantly in the forms of quartz, tridymite, and * cristobalite*, is a ubiquitous mineral in the Earth’s crust and a key component of…

Continue ReadingComprehensive Clinical Update on Silicosis: Pathophysiology, Diagnosis, Management, and Prevention—Incorporating 2024 Guidelines and Evidence

Comprehensive Clinical Update on Barrett’s Esophagus: Pathophysiology, Risk Stratification, Diagnosis, Management, and Surveillance Based on Current Evidence

1. Definition & Pathogenesis Barrett’s esophagus (BE) is a premalignant condition characterized by the metaplastic replacement of the normal stratified squamous epithelium of the distal esophagus with specialized intestinal metaplasia…

Continue ReadingComprehensive Clinical Update on Barrett’s Esophagus: Pathophysiology, Risk Stratification, Diagnosis, Management, and Surveillance Based on Current Evidence

Comprehensive Update on Urothelial Carcinoma of the Bladder: Clinical Presentation, Diagnosis, Staging, and Evidence-Based Management for Clinicians

Epidemiology and Pathobiology Urothelial carcinoma (UC), formerly termed transitional cell carcinoma (TCC), accounts for >90% of primary bladder malignancies and remains the fifth most common cancer in the United States…

Continue ReadingComprehensive Update on Urothelial Carcinoma of the Bladder: Clinical Presentation, Diagnosis, Staging, and Evidence-Based Management for Clinicians